dyadams.bsky.social
@dyadams.bsky.social
Pleased to share that our CPD article about the menopause in women with intellectual disabilities has been published in Learning Disability Practice. journals.rcni.com/learning-dis...
Thank you to co authors Dr Chetan Shah and Dr Indermeet Sawhney
Menopause as a factor in psychological, behavioural and cognitive changes in women with learning disabilities
Menopause as a factor in psychological, behavioural and cognitive changes in women with learning disabilities
journals.rcni.com
November 3, 2025 at 12:32 AM
Passed PhD viva (minor corrections) Rewarding experience discussing research on deprescribing psychotropic medicines in people with intellectual disabilities. Thank you examiners Rohit Shankar and Hayley Crawford, and supervisors @peterlangdon.bsky.social @profhastings.bsky.social Ian Maidment.
September 14, 2025 at 3:59 PM
Now published open access www.frontiersin.org/journals/psy...
August 20, 2025 at 6:03 AM
Delighted to share that my final PhD study has been provisionally accepted in Frontiers in Psychiatry
www.frontiersin.org/journals/psy...
Thank you to co-authors
@peterlangdon.bsky.social @profhastings.bsky.social & ian maidment

Full paper to follow soon.
Frontiers | Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi Study
Overprescribing psychotropic medication for people with intellectual disabilities increases the risk of adverse effects and has prompted deprescribing initia...
www.frontiersin.org
August 4, 2025 at 11:33 PM
Study looking at pharmacists' perspectives of psychotropic deprescribing in people with intellectual disabilities published open access. @peterlangdon.bsky.social @profhastings.bsky.social professor ian maidment & Dr. Olivia hewitt.
#deprescribing #pharmacists
www.tandfonline.com/doi/full/10....
Pharmacists’ Perspectives on Deprescribing Psychotropic Medicines in People with Intellectual Disabilities
Psychotropic medicines are sometimes inappropriately prescribed for individuals with intellectual disabilities without a clinical diagnosis of a mental illness, increasing risks of side effects and...
www.tandfonline.com
June 26, 2025 at 5:17 PM
Pleased to share that our opinion piece on Psychotropic deprescribing in ethnic minority individuals with a learning disability
has been published in the Pharmaceutical Journal. A big thank you to my co author Dr Hassan Mahmood
pharmaceutical-journal.com/article/opin...
Psychotropic deprescribing in ethnic minority individuals with a learning disability requires a more nuanced approach
Health inequalities are pervasive across our healthcare system, affecting different patients in different ways and requiring an increasingly nuanced approach to tackle them. For individuals from an et...
pharmaceutical-journal.com
January 23, 2025 at 3:12 PM
Had a brilliant couple of days in London at the Seattle Club Conference. Great range of oral and poster presentations, focus on inclusive research and addressing health inequalities in people with intellectual disabilities. Thank you to Deborah Chinn, Rory Sheehan and rest of organising team
December 14, 2024 at 11:42 PM
Delighted to have been at the Seattle Club Conference in London with Priyanka Chaudhuri presenting the SMILE project poster scoping review looking at issues related to medication use for people with intellectual disabilities and interventions to address them.
December 14, 2024 at 11:38 PM
Reposted
Holly is looking for speech and language therapists to take part in her research about accessible health information @healthlibraryholly.bsky.social
December 12, 2024 at 1:53 PM
Had a great couple of days at Seattle Club Conference in London. Delighted to be able to share the outcomes of study looking at pharmacists perspectives on psychotropic deprescribing in people with intellectual disabilities
The next talk in our session on mental health at medication at #seattleclub is with PhD student Danielle Adams from the University of Warwick. Her talk looks at pharmacists' perspectives on de-prescribing psychotropic medicines in people with intellectual disabilities.
December 14, 2024 at 10:44 PM